mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NC_000913_3_bme_pgi | 526,792 | 0 | A | C | 25.1% | 273.0 / 141.3 | 173 | S1178R (AGC→CGC) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_bme_pgi | 526,796 | 0 | C | G | 25.1% | 356.6 / 138.7 | 167 | A1179G (GCG→GGG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_bme_pgi | 4,296,061 | 0 | C | T | 25.1% | 440.3 / 160.7 | 256 | intergenic (+266/+376) | gltP/yjcO | glutamate/aspartate:proton symporter/Sel1 family TPR‑like repeat protein |
| * | NC_000913_3_bme_pgi | 526,800 | 0 | A | G | 22.7% | 325.5 / 93.5 | 163 | E1180E (GAA→GAG) | rhsD | Rhs protein with DUF4329 family putative toxin domain; putative neighboring cell growth inhibitor |
| * | NC_000913_3_bme_pgi | 225,465 | 0 | A | . | 21.1% | 38.0 / 10.4 | 19 | intergenic (+8/‑35) | ileV/alaV | tRNA‑Ile/tRNA‑Ala |
| Marginal new junction evidence (lowest skew 10 of 879 shown) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | NC_000913_3_bme_pgi | 1097172 = | NA (NA) | 27 (0.190) | 22/260 | 12.7 | 25.0% | intergenic (+343/+393) | ycdU/serX | putative inner membrane protein/tRNA‑Ser |
| ? | NC_000913_3_bme_pgi | 1097188 = | 83 (0.570) | intergenic (+359/+377) | ycdU/serX | putative inner membrane protein/tRNA‑Ser | |||||
| * | ? | NC_000913_3_bme_pgi | 1096988 = | 154 (1.050) | 27 (0.190) | 22/260 | 12.7 | 15.2% | intergenic (+159/+577) | ycdU/serX | putative inner membrane protein/tRNA‑Ser |
| ? | NC_000913_3_bme_pgi | 1097191 = | NA (NA) | intergenic (+362/+374) | ycdU/serX | putative inner membrane protein/tRNA‑Ser | |||||
| * | ? | NC_000913_3_bme_pgi | 4542683 = | 138 (0.940) | 19 (0.140) | 19/248 | 13.3 | 12.7% | intergenic (+49/‑433) | fimE/fimA | tyrosine recombinase/inversion of on/off regulator of fimA/major type 1 subunit fimbrin (pilin) |
| ? | NC_000913_3_bme_pgi | 4542997 = | 133 (0.980) | intergenic (+363/‑119) | fimE/fimA | tyrosine recombinase/inversion of on/off regulator of fimA/major type 1 subunit fimbrin (pilin) | |||||
| * | ? | NC_000913_3_bme_pgi | = 597105 | 150 (1.030) | 25 (0.190) +ATCCATTTATTATCTT |
17/234 | 13.4 | 16.0% | intergenic (+132/‑26) | cusC/cusF | copper/silver efflux system, outer membrane component/periplasmic copper‑ and silver‑binding protein |
| ? | NC_000913_3_bme_pgi | = 803487 | 149 (1.020) | intergenic (+167/‑16) | ybhI/ybhJ | putative DASS family tricarboxylate or dicarboxylate transporter/aconitase family protein | |||||
| * | ? | NC_000913_3_bme_pgi | 1097372 = | NA (NA) | 26 (0.180) | 20/260 | 13.5 | 21.0% | intergenic (+543/+193) | ycdU/serX | putative inner membrane protein/tRNA‑Ser |
| ? | NC_000913_3_bme_pgi | 1097531 = | 100 (0.680) | intergenic (+702/+34) | ycdU/serX | putative inner membrane protein/tRNA‑Ser | |||||
| * | ? | NC_000913_3_bme_pgi | 1097434 = | NA (NA) | 24 (0.170) | 19/260 | 13.9 | 32.5% | intergenic (+605/+131) | ycdU/serX | putative inner membrane protein/tRNA‑Ser |
| ? | NC_000913_3_bme_pgi | 1097447 = | 51 (0.350) | intergenic (+618/+118) | ycdU/serX | putative inner membrane protein/tRNA‑Ser | |||||
| * | ? | NC_000913_3_bme_pgi | 1097253 = | NA (NA) | 24 (0.170) | 19/260 | 13.9 | 46.7% | intergenic (+424/+312) | ycdU/serX | putative inner membrane protein/tRNA‑Ser |
| ? | NC_000913_3_bme_pgi | 1097266 = | 28 (0.190) | intergenic (+437/+299) | ycdU/serX | putative inner membrane protein/tRNA‑Ser | |||||
| * | ? | NC_000913_3_bme_pgi | 1097069 = | 108 (0.740) | 24 (0.170) | 19/260 | 13.9 | 24.2% | intergenic (+240/+496) | ycdU/serX | putative inner membrane protein/tRNA‑Ser |
| ? | NC_000913_3_bme_pgi | 1097450 = | 45 (0.310) | intergenic (+621/+115) | ycdU/serX | putative inner membrane protein/tRNA‑Ser | |||||
| * | ? | NC_000913_3_bme_pgi | 1097069 = | 108 (0.740) | 24 (0.170) | 19/260 | 13.9 | 26.9% | intergenic (+240/+496) | ycdU/serX | putative inner membrane protein/tRNA‑Ser |
| ? | NC_000913_3_bme_pgi | 1097269 = | 25 (0.170) | intergenic (+440/+296) | ycdU/serX | putative inner membrane protein/tRNA‑Ser | |||||
| * | ? | NC_000913_3_bme_pgi | 1097007 = | 140 (0.960) | 21 (0.150) | 19/260 | 13.9 | 13.3% | intergenic (+178/+558) | ycdU/serX | putative inner membrane protein/tRNA‑Ser |
| ? | NC_000913_3_bme_pgi | 1097172 = | NA (NA) | intergenic (+343/+393) | ycdU/serX | putative inner membrane protein/tRNA‑Ser | |||||